Accéder au contenu
Merck
  • Synthesis and preliminary in vitro biological evaluation of 4-[(4-hydroxyphenyl)sulfanyl]but-3-en-2-one, a 4-mercaptophenol derivative designed as a novel bifunctional antimelanoma agent.

Synthesis and preliminary in vitro biological evaluation of 4-[(4-hydroxyphenyl)sulfanyl]but-3-en-2-one, a 4-mercaptophenol derivative designed as a novel bifunctional antimelanoma agent.

Journal of medicinal chemistry (2009-07-16)
Paolo Ruzza, Antonio Rosato, Alberto Nassi, Maria Rondina, Matteo Zorzin, Carlo Riccardo Rossi, Maura Floreani, Luigi Quintieri
RÉSUMÉ

We report the synthesis and preliminary in vitro biological evaluations of 4-[(4-hydroxyphenyl)sulfanyl]but-3-en-2-one, a compound designed as a potential bifunctional antimelanoma agent, bearing both a tyrosinase-activatable phenolic moiety and a GSH-reactive alpha,beta-unsaturated carbonyl group. Both the E (1) and Z (2) isomers of the synthesized compound proved to be very good substrates of mushroom tyrosinase, reacted quickly with GSH at physiological pH, and showed a significant cytotoxic activity against B16F1 murine melanoma cells.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
4-Methoxyphenol, purum, ≥98.0% (HPLC)